Rhode Island Telemedicine Laws: Licensure, Opioids, Parity

Rhode Island requires its own license for a physician treating a patient located in the state and offers no telehealth registration. Its Telemedicine Coverage Act, R.I. Gen. Laws chapter 27-81, counts audio-only calls as telemedicine, reaches the state Medicaid program by its own definition, and requires payment parity for three groups of in-network providers. Two controlled-substance rules are most likely to catch a telehealth practice: the Department of Health does not issue a state controlled substance registration to practitioners prescribing by telemedicine from outside Rhode Island, and a 1974 statute requires named prescribers to perform an original physical examination before prescribing a Schedule II, III, or IV drug.

Licensure: a Rhode Island license, with narrow exceptions

Under R.I. Gen. Laws § 5-37-12, a person not lawfully authorized and registered who practices medicine after receiving, or with intent to receive, compensation faces up to three years' imprisonment, a fine, or both, and may not collect for the services.

The exceptions sit in § 5-37-16.2, which lets a physician licensed and in good standing elsewhere practice "for a patient located in this state" under five circumstances "only": federal employment; presence on a singular occasion with an air ambulance or organ harvesting team; a consultation requested on a singular occasion by a Rhode Island-licensed physician, or teaching assistance, for no more than seven days, whether or not the physician is physically present; up to seven days as an uncompensated volunteer at a charitable function; and care for a traveling sports team under a written agreement. One limit applies to consultations: a physician not present in the state may not consult with a Rhode Island patient who lacks a physician-patient relationship with that physician unless the patient is in the physical presence of a Rhode Island-licensed physician. Consulting and volunteer physicians must notify the Board in writing of their intent to practice beforehand or as soon as practicable, and no later than seven days after the consultation. With the director's prior written permission, sought by a Rhode Island-licensed physician for good cause, the last three exceptions may be extended, to no more than 30 days a year. The section names physicians only, a violation is treated as unauthorized practice under § 5-37-12, and it contains no follow-up or border exception.

Rhode Island enacted the Interstate Medical Licensure Compact (S 2606 Sub A, P.L. 2022, ch. 285; statutory effective date June 29, 2022), but it is not yet live. The state has issued Nurse Licensure Compact multistate licenses since January 8, 2024, and is a PSYPACT state effective July 1, 2023, under H 7501. It has enacted the Physical Therapy Compact and the Counseling Compact, neither yet issuing privileges. See the cross-state licensing tracker.

Prescribing: registration, an exam statute, 2026 opioid changes, and mandatory e-prescribing

The physician rule, 216-RICR-40-05-1 § 1.5.9(H)(2) (current version effective August 26, 2026), holds online treatment and prescribing to face-to-face standards. Treatment, including a prescription, "based solely on an online questionnaire without an appropriate evaluation" is unprofessional conduct, and asynchronous evaluation "without contemporaneous real-time, interactive exchange between the physician and patient, is not appropriate." The Board's undated guidelines, which are guidance rather than a promulgated rule, add that a documented evaluation, including a history and physical evaluation adequate to establish diagnoses, must precede treatment, and they define physical evaluation as using the tools available through telemedicine and the internet to reach a reasonable diagnostic conclusion; that failing to refer a patient whose presentation suggests the need for an in-person physical examination is unprofessional conduct; and that prescribing controlled substances without an established in-person physician-patient relationship is prohibited, except by a covering physician under an established coverage agreement for a short duration. The 2026 rule adopted the guidelines' online-questionnaire language but not that in-person controlled-substance sentence.

R.I. Gen. Laws § 21-28-3.24, part of the state's Uniform Controlled Substances Act, bars any physician, dentist, osteopath, chiropodist, or veterinarian from administering, dispensing, or prescribing a controlled substance in Schedules II, III, and IV "except after an original physical examination" of the patient. The section has no telemedicine exception, does not define the term, and does not name advanced practice registered nurses or physician assistants. It carries no penalty of its own. On its face, the act's general penalty clause, § 21-28-4.09, reaches any provision without a specified penalty and allows up to one year of imprisonment, a fine, or both; we found no court decision or Department of Health statement applying that clause to § 21-28-3.24. For physicians, violating any state controlled-substance law is also unprofessional conduct under § 5-37-5.1(26).

Registration is the larger barrier. Every practitioner who prescribes controlled substances in Rhode Island must hold a state controlled substance registration under § 21-28-3.02. The Department of Health's application materials require a Rhode Island clinical address where the practitioner evaluates patients in person, with a DEA registration at that same address, and state that a registration will not be granted to practitioners providing care to Rhode Island patients by telemedicine from outside the state. The Department's nursing application guidance puts it directly: "Rhode Island does not allow the prescribing of controlled substances via telemedicine from outside of the state."

P.L. 2026, chapters 313 and 314, effective on passage June 23, 2026, rewrote the opioid statute, § 21-28-3.20. Its first subsection now refers to prescribing "after completing a comprehensive assessment of pain experienced by a patient and/or for opioid use disorder." Opioids for acute pain may be started only when non-opioid therapies have failed or, on clinical assessment, benefits outweigh risks. Initial adult prescriptions for acute pain are capped at a seven-day supply, and prescriptions for minors at 20 doses. Before any opioid prescription, the practitioner must discuss and document risks and alternatives and offer naloxone. Before initiating opioid therapy or refilling an opioid prescription, the practitioner or an authorized designee must review the prescription drug monitoring program (PDMP) and obtain any methadone or buprenorphine history, then review the PDMP at least every three months for patients on continuous opioid therapy for pain for three months or longer. Medications prescribed or dispensed for substance use disorder or opioid dependence are exempt from subsection (a), which holds the supply limits and the discussion and naloxone duties, and from subsection (c), but not from the PDMP review in subsection (b). Practitioners must also register with the PDMP to obtain or renew controlled-substance authority, under § 21-28-3.32(l).

The Department of Health's rule, 216-RICR-20-20-4 § 4.4 (current version effective January 4, 2022), adds duties including an ICD-10 code on every controlled-substance prescription and naloxone co-prescribing in three listed situations. It still states a 30 MME, 20-dose cap for initial acute-pain prescriptions to patients who have not received opioids in the last 30 days. The 2026 act removed that cap from the statute but did not repeal the rule, and a prescriber can meet both the statute's seven-day ceiling and the rule's stricter cap; until the Department amends the rule, treat the 20-dose, 30 MME limit as still in force.

Electronic prescribing is mandatory. Section 21-28-3.18(d)(3) and rule § 4.4(K) have required electronic transmission of Schedule II–V prescriptions since January 2, 2020, subject to eight listed exceptions, such as a temporary technological failure, and a waiver for undue economic hardship. Medicare Part D separately requires at least 70 percent of Part D Schedule II–V prescriptions to be electronic under 42 CFR 423.160, subject to exceptions and waivers.

Federal law adds a separate layer for controlled substances. Under the temporary rule DEA and HHS published December 31, 2025 (90 FR 61301), which runs through December 31, 2026, a DEA-registered practitioner may prescribe Schedule II–V controlled substances after a real-time audio-video telemedicine encounter without a prior in-person evaluation, when the rule's other conditions are met; audio-only encounters qualify only for Schedule III–V narcotic medications approved by the FDA to treat opioid use disorder. See our guide to federal telehealth laws.

Consent: Medicaid-only, plus an AI notice

Neither chapter 27-81 nor the physician rule requires telehealth consent; the Board's guidelines recommend a consent agreement only for patient-physician e-mail and text communications. Rhode Island Medicaid's Telemedicine Billing Guidance requires written or verbal consent to telehealth in lieu of in-person care and, for audio-only calls, documented informed verbal consent plus confirmation that the member was offered video and declined or lacked the technology. Separately, P.L. 2026, chapters 199 and 372, require providers and facilities that use artificial intelligence to document in-person or telehealth visits to notify patients and review the AI-generated documentation for accuracy after the visit.

Medicaid: parity by statute, limits by guidance

Chapter 27-81 defines "health insurer" to include Rhode Island Medicaid and its contracted managed care entities, so the parity rules below apply to Medicaid. The EOHHS guidance, effective September 1, 2025, requires the patient to participate in real time, services to be medically necessary and clinically appropriate, and providers to offer both telehealth and in-person care. Remote patient monitoring and store-and-forward are not reimbursable unless specified elsewhere; e-mail, text, and fax contacts are excluded.

Audio-only is covered "only when clearly justified in the medical record." It is not permitted for services requiring visual or physical assessment, such as physical therapy, occupational therapy, neurological assessments, and dermatologic consultations. New patient visits should generally include video unless the record justifies audio-only. Each call must document start and end times, identity verification, verbal consent, the rationale for audio-only, clinical content, and any follow-up plan. Out-of-state providers, including those in border communities, are reimbursed only with an active, unrestricted Rhode Island license and Medicaid enrollment. Claims billed after August 1, 2026, for 17 physical medicine codes (97010 through 97140) with a telehealth place of service are denied.

Private insurance: coverage parity, partial payment parity

Section 27-81-4 bars excluding a service solely because it is delivered by telemedicine, "so long as such healthcare services are medically necessary and clinically appropriate" for telemedicine. Payment parity is narrower: under subsection (b)(2), medically necessary and clinically appropriate telemedicine services by in-network primary care providers, registered dietitian nutritionists, and behavioral health providers "shall be reimbursed at rates not lower than" the same provider's in-person services. Cost-sharing may not exceed the in-person amount, and prior authorization, benefit determination, and utilization review may apply but may be no more stringent than for the same in-person service. Insurers may not dictate technology beyond compliance with law. The section covers plans issued, reissued, or delivered on and after January 1, 2018, excludes short-term travel, accident-only, limited or specified disease, individual conversion, Medicare-related plans, and other similar coverage under state or federal governmental plans, and carries no sunset.

What to watch

First, whether the Department of Health amends 216-RICR-20-20-4 to match the 2026 opioid statute. Second, the Interstate Medical Licensure Compact: S 2458 (2026), which would have required implementation no later than July 1, 2026, did not become law, but the FY 2027 budget (P.L. 2026, ch. 84, Article 12) added § 5-91-26, barring dissemination of criminal history records to the compact, and enacted the Physician Assistant Licensure Compact as chapter 5-54.1. Third, H 7278 (2026), which would have let clinicians diagnose and treat by store-and-forward technology when consistent with the standard of care, did not become law. Fourth, the federal DEA rule, which together with § 21-28-3.24 and the Department of Health's registration policy sets the room for remote controlled-substance prescribing. For context, see how state telemedicine laws work.